Manus Aktteva Biopharma LLP, a global supplier of Olanzapine (Form I and II), 132539-06-1 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.
The list of intermediates for Olanzapine (Form I and II) (CAS No.: 132539-06-1) will be updated soon.
If you can not locate your required intermediate for Olanzapine (Form I and II) (CAS No.: 132539-06-1) on this page, you may send us a sourcing request for the specific Olanzapine (Form I and II) (CAS No.: 132539-06-1) intermediate you are looking for along with its Cas No., and the Intermediate name and we shall come back to you promptly with more details. Please click here to send an email.
Olanzapine (originally branded Zyprexa) is an atypical antipsychotic. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder.
Are you looking for Olanzapine (Form I and II) (CAS No.: 132539-06-1) with documentation like CEP / COS, PMDA - JAPAN, DMF - CANADA, TGA - AUSTRALIA, DMF (OPEN PART), DMF (CLOSED PART), MHRA - UK, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DCGI, ICH, COPP, TDMF, Written Confirmation? Please click here to send us sourcing request.